Fluoxetine and the bleeding time.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Archives of Pathology & Laboratory Medicine

• Publication date

  1990-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 2363631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub).

  1989cited by this paper
• Treatment of fibrositis with fluoxetine hydrochloride (Prozac).

  1989cited by this paper
• Evidence for the existence of at least two different binding sites for 5HT-reuptake inhibitors within the 5HT-reuptake system from human platelets.

  1988cited by this paper
• Fluoxetine: clinical pharmacology and physiologic disposition.

  1985cited by this paper
• The side effect profile and safety of fluoxetine.

  1985cited by this paper

• Demonstration of an action pathway in mouse platelets leading to prolongation of bleeding time by fluoxetine.

  2020cites this paper
• Antidepressant drug use and subdural hematoma risk

  2020cites this paper
• Differential effects of antidepressant subgroups on risk of acute myocardial infarction: A nested case–control study

  2020cites this paper
• Intrathecal Drug Delivery for Chronic Pain Syndromes: A Review of Considerations in Practice Management.

  2020cites this paper
• Major Depressive Disorder in Medical Illness: A Review of Assessment, Prevalence, and Treatment Options

  2019cites this paper
• Peripheral serotonin causes dengue virus-induced thrombocytopenia through 5HT2 receptors.

  2019cites this paper
• Risk of Bleeding in Patients on Full-Dose Enoxaparin With Venous Thromboembolism and Selective Serotonin Reuptake Inhibitors

  2017cites this paper
• Regional Anesthesia and Anticoagulation

  2017cites this paper
• Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta‐analysis of observational studies

  2017cites this paper
• Sertraline-induced periorbital purpura: a case report

  2015cites this paper
• Bleeding Complications in the Course of Treatment with Antidepressants in Elderly Patients

  2015cites this paper
• Use of serotonergic antidepressants and bleeding risk in patients undergoing surgery.

  2014cites this paper
• Acquired Disorders of Platelet Function

  2013cites this paper
• an integrated care pathway. Part 2: Treatment alternatives Depression after stroke: a review of the evidence base to inform the development of

  2013cites this paper
• Psychotropic drug-related problems in the elderly

  2012cites this paper
• Effects of Selective Serotonin Reuptake Inhibitors on Platelet Function

  2011cites this paper
• Psychotropic drug safety issues: continuing vigilance is needed

  2010cites this paper
• Use of selective serotonin reuptake inhibitors and risk of re-operation due to post-surgical bleeding in breast cancer patients: a Danish population-based cohort study

  2010cites this paper
• Les troubles urinaires et vésicaux induits par les médicaments

  2009cites this paper
• Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.

  2008cites this paper
• CHAPTER 58 – Acquired Disorders of Platelet Function

  2007cites this paper
• Influence of antidepressants on hemostasis

  2007cites this paper
• Acute Compartment Syndrome Due to Ruptured Baker Cyst after Nonsurgical Management of an Anterior Cruciate Ligament Tear

  2006influential citation
• Antidepressants and risk of upper gastrointestinal bleeding.

  2006cites this paper
• Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?

  2006cites this paper
• SSRIs and Upper Gastrointestinal Bleeding

  2006cites this paper
• Monoaminergic‐based Pharmacotherapy for Depression

  2005cites this paper
• Intraoperative Nasal Bleeding Complication of Treatment With the Selective Serotonin Uptake Inhibitor Sertraline

  2005cites this paper
• Coated-platelets: an emerging component of the procoagulant response.

  2005cites this paper
• Selective serotonin re-uptake inhibitors and the risk of bleeding

  2005cites this paper
• Do SSRIs cause gastrointestinal bleeding?

  2004cites this paper
• Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease?

  2004cites this paper
• Symptomatic reversible duodenal compression due to iatrogenic retroperitoneal hematoma.

  2004cites this paper
• Trombocitopatía hemorrágica secundaria al uso de antidepresivos en cirugía estética

  2004cites this paper
• COAT platelets

  2003cites this paper
• A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients.

  2003cites this paper
• [Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine].

  2003cites this paper
• Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients.

  2003cites this paper
• Serotonin reuptake inhibitors in Raynaud ’ s phenomenon

  2003cites this paper
• Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study.

  2003cites this paper
• Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation

  2003cites this paper
• Ecchymoses as an adverse effect of fluoxetine treatment

  2003cites this paper
• Fluoksetin Kullan›m› ile İlişkili Ekimoz: Olgu Sunumu

  2002cites this paper
• Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives

  2002cites this paper
• Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study

  2001cites this paper
• [Bleeding from selective serotonin reuptake inhibitors: a case report].

  2001cites this paper
• SSRI-induced bleeding: two case reports.

  2001cites this paper
• Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England.

  2001cites this paper
• Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.

  2001cites this paper
• Syndromes hémorragiques sous antidépresseurs inhibiteurs sélectifs de la recapture de la sérotonine (ISRS). A propos de sept cas et revue de la littérature

  2000cites this paper
• Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.

  2000cites this paper
• [Spontaneous hematoma: thoughts about selective serotonin uptake inhibitors].

  2000cites this paper
• [Hemorrhagic syndromes related to selective serotonin reuptake inhibitor (SSRI) antidepressants. Seven case reports and review of the literature].

  2000cites this paper
• Antidepressant drugs: a potential new drug cause of upper gastrointestinal bleeding.

  2000cites this paper
• Paroxetine decreases platelet serotonin storage and platelet function in human beings

  2000cites this paper
• Depression really does hurt your heart: stress, depression, and cardiovascular disease.

  2000cites this paper
• Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.

  2000cites this paper
• Can treating depression reduce mortality after an acute myocardial infarction?

  1999cites this paper
• Abnormal clotting and production of factor VIII inhibitor in a patient treated with venlafaxine.

  1999cites this paper
• Study of haemostasis in depressive patients treated with fluoxetine

  1998cites this paper
• Der Einfluß von selektiven Serotonin-Wiederaufnahme- inhibitoren auf die Blutgerinnung

  1998cites this paper
• Selective Serotonin Reuptake Inhibitor-Induced Disturbances of Haemostasis

  1998cites this paper
• [The effect of selective serotonin-reuptake inhibitors in blood coagulation].

  1998cites this paper
• Aplastic anaemia during treatment with fluoxetine.

  1998cites this paper
• Selective Serotonin Reuptake Inhibitor-Induced Disturbances of Haemostasisand Therapeutic Implications

  1998cites this paper
• The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment.

  1998cites this paper
• Treatment of depression--newer pharmacotherapies.

  1998cites this paper
• Venlafaxine and Ecchymosis

  1997cites this paper
• Rational Drug Use in the Treatment of Depression

  1997cites this paper
• Fluoxetine tenth anniversary update: the progress continues.

  1997cites this paper
• Subhyaloid haemorrhage with fluoxetine

  1996cites this paper
• Bruising Associated with the Use of Fluoxetine

  1996cites this paper
• Patient perceptions of cataract surgery pre-operatively

  1996cites this paper
• Effects of Serotonin Reuptake Inhibitors on Hemostasis

  1996cites this paper
• Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.

  1996cites this paper
• Fluoxetine and hemostatic function: a pilot study.

  1995cites this paper
• Pharmacokinetic and Pharmacodynamic Evaluation of Warfarin and Nefazodone Coadministration in Healthy Subjects

  1995cites this paper
• Serotonin reuptake inhibitors in Raynaud's phenomenon

  1995cites this paper
• Serotonin reuptake inhibitors in Raynaud's phenomenon.

  1995cites this paper
• Selective serotonin reuptake inhibitors: adverse effects, toxicity and interactions.

  1994cites this paper
• Fluoxetine: adverse effects and drug-drug interactions.

  1993cites this paper
• The human pharmacology of fluoxetine.

  1992cites this paper
• Abnormal Platelet Aggregation Associated with Fluoxetine Therapy

  1992cites this paper
• Acquired abnormalities of platelet function.

  1991cites this paper
• Acquired abnormalities of platelet function [2]

  1991cites this paper